They are profitable with net cash increasing. They are only EBITDA negative.
We see the issues differently, the main restriction on this business will be that they stepped out of the market for a year. The accellerated amortisation of the loan book will take a while to catch up to.
- Forums
- ASX - By Stock
- Ann: WZR Q3FY24 Market Update
WZR
wisr limited
Add to My Watchlist
0.00%
!
2.5¢

They are profitable with net cash increasing. They are only...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.87M |
Open | High | Low | Value | Volume |
2.5¢ | 2.6¢ | 2.5¢ | $5.034K | 199.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 2006482 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.6¢ | 85000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 2006482 | 0.025 |
5 | 2510000 | 0.024 |
2 | 140000 | 0.023 |
2 | 230000 | 0.022 |
1 | 40000 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.026 | 85000 | 1 |
0.027 | 699463 | 6 |
0.028 | 502402 | 7 |
0.029 | 735819 | 5 |
0.030 | 1000773 | 7 |
Last trade - 15.17pm 04/07/2025 (20 minute delay) ? |
Featured News
WZR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online